Monopar Therapeutics (MNPR) EBIT (QoQ) (2017 - 2025)
Monopar Therapeutics (MNPR) EBIT (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -26.55% |
| Jun 30, 2025 | -0.39% |
| Sep 30, 2024 | 11.96% |
| Jun 30, 2024 | -3.79% |
| Sep 30, 2023 | 11.26% |
| Jun 30, 2023 | 7.80% |
| Mar 31, 2023 | 13.20% |
| Dec 31, 2022 | -20.84% |
| Sep 30, 2022 | 12.88% |
| Jun 30, 2022 | -12.46% |
| Mar 31, 2022 | 8.35% |
| Dec 31, 2021 | -9.03% |
| Sep 30, 2021 | -17.52% |
| Jun 30, 2021 | -10.43% |
| Mar 31, 2021 | 16.19% |
| Dec 31, 2020 | -37.18% |
| Sep 30, 2020 | -12.56% |
| Jun 30, 2020 | -28.88% |
| Mar 31, 2020 | 7.26% |
| Dec 31, 2019 | -61.29% |